In our patient, disease progression was associated with clonal evolution of Ph-positive sub-clones, as evidenced by the demonstration of additional BCR-ABL1 mutations, but also with occurrence of a Ph-negative sub-clone that presented as an overt MDS/MPN-like disease with massive BM fibrosis. This evidence concerns the gene ABL1 and myelodysplastic syndrome.